首页 | 本学科首页   官方微博 | 高级检索  
     

胃癌患者血清可溶性B7 H4的检测及其临床意义
引用本文:华建江,姜健,胡国艳,郑淑华,刘伟,吕晶,徐军发. 胃癌患者血清可溶性B7 H4的检测及其临床意义[J]. 山东大学学报(医学版), 2009, 47(8): 100-102
作者姓名:华建江  姜健  胡国艳  郑淑华  刘伟  吕晶  徐军发
作者单位:1. 广州医学院附属深圳沙井人民医院检验科, 广东 深圳 518104;
2. 深圳市福田区中医院检验科, 广东 深圳 518000;
3. 广东医学院临床免疫学教研室, 广东 东莞 523808
基金项目:广东省科技计划项目(2006B36002021);;深圳市科技计划项目(200803231);;深圳市宝安区科技计划项目(2008174);;东莞市科技计划项目(2008108101054)
摘    要:目的检测胃癌患者血清中可溶性B7 H4(sB7 H4)的水平并探讨其临床意义。方法应用酶联免疫吸附试验(ELISA)夹心法检测61例胃癌患者与51例正常人血清sB7 H4水平,分析其与病理类型、治疗前后、胃癌其他血清标志物的相关性。结果胃癌患者血清sB7 H4水平(49.14±16.16)μg/L明显高于正常人(32.67±12.28)μg/L,P<0.01。低分化腺癌患者sB7 H4水平(64.51±20.67)μg/L高于高分化腺癌(36.78±13.39)μg/L、粘液腺癌(42.79±12.31)μg/L和印戒细胞癌(44.62±12.27)μg/L,P<0.05。手术前胃癌患者血清sB7 H4水平(58.09±15.28)μg/L明显高于术后(38.58±9.49)μg/L,P<0.01。胃癌患者血清sB7 H4水平与CEA、CA19 9水平呈正相关(P<0.01)。结论胃癌患者血清中高水平的sB7 H4及其与病理类型、治疗情况、及其他肿瘤标志物相关,提示sB7 H4可能在胃癌的发生发展中有重要作用,可为胃癌的诊断和治疗提供一种新的靶位点。

关 键 词:胃肿瘤;B7 H4;ELISA;夹心法  
收稿时间:2009-03-03

Expression of soluble B7-H4 in the serum and its clinical significance in gastric cancer
HUA Jian jiang,JIANG Jian,HU Guo yan,ZHENG Shu hua,LIU Wei Lu Jing,XU Jun fa. Expression of soluble B7-H4 in the serum and its clinical significance in gastric cancer[J]. Journal of Shandong University:Health Sciences, 2009, 47(8): 100-102
Authors:HUA Jian jiang  JIANG Jian  HU Guo yan  ZHENG Shu hua  LIU Wei Lu Jing  XU Jun fa
Abstract:To determine the serum level of soluble B7 H4 in gastric cancer and to explore its clinical significance. MethodUsing the ELISA sandwich method, the serum level of soluble B7 H4 was determined in 61 cases of gastric cancer and 51 cases of normal controls, then correlations between soluble B7 H4 and pathological types, before and after surgical treatment and other serum markers of gastric cancers were analyzed. ResultsThe serum level of soluble B7 H4 in gastric cancer [(49.14±16.16)μg/L]was significantly higher than that in normal people[(32.67±12.28)μg/L], and there was a significant difference (P<0.01). The serum level of soluble B7 H4 in poorly differentiated adenocarcinoma [(64.51±20.67)μg/L]was higher than that in well differentiated adenocarcinoma[(36.78±13.39)μg/L], mucinous adenocarcinoma[(42.79±12.31)μg/L] , and signet ring cell carcinoma[(44.62±12.27)μg/L], and there were significant differences among them (P<0.05). The serum level of soluble B7 H4 in gastric cancer before surgical treatment[(58.09±15.28)μg/L]was higher than that in gastric cancer after surgical treatment[(38.58±9.49)μg/L](P<0.01). The serum level of sB7 H4 in gastric cancer was positivelycorrelated with serum levels of CEA and CA19 9(P<0.01). ConclusionA high level of serum soluble B7 H4 in gastric cancer has a positive relationship to pathological types, surgical treatment and other serum markers of gastric cancers, which reveals that soluble B7 H4 plays an important role in cancer generation and development.
Keywords:Gastric neoplasms  B7-H4  ELISA  Sandwich method  
本文献已被 CNKI 等数据库收录!
点击此处可从《山东大学学报(医学版)》浏览原始摘要信息
点击此处可从《山东大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号